IGF1 and metabolic dysfunction-associated steatotic liver disease: NAFLD patients demonstrated significantly lower serum levels of IGF-1 (mean value 112 ng/mL) compared to those in 2911 sex- and age-matched healthy people (mean value 121 ng/mL, p < 0.0001).